DIA
BIIB icon

Dana Investment Advisors’s Biogen BIIB Stock Holding History

Dana Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,023
Closed -$265K – 531
2023
Q4 		$265K Sell
1,023
-10
-1% -$2.46K 0.01% 388
2023
Q3 		$265K Buy
+1,033
New +$276K 0.01% 376
2015
Q2 		– Sell
-17,073
Closed -$7.21M – 265
2015
Q1 		$7.21M Sell
17,073
-4,911
-22% -$1.94M 0.35% 70
2014
Q4 		$7.46M Buy
21,984
+4,118
+23% +$1.33M 0.3% 90
2014
Q3 		$5.91M Sell
17,866
-472
-3% -$156K 0.34% 71
2014
Q2 		$5.78M Buy
18,338
+102
+0.6% +$30.7K 0.34% 76
2014
Q1 		$5.58M Sell
18,236
-3,628
-17% -$1.15M 0.35% 81
2013
Q4 		$6.11M Buy
21,864
+338
+2% +$87.4K 0.39% 77
2013
Q3 		$5.18M Buy
+21,526
New +$4.82M 0.37% 80

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dana Investment Advisors's BIIB Position: Q1 2024 in Review

Dana Investment Advisors sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,023 shares — an estimated $265K sold.

Dana Investment Advisors first reported a position in BIIB in Q3 2013 and held it in 9 quarters. The position peaked at $7.46M in Q4 2014. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Dana Investment Advisors reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Dana Investment Advisors sold 1,023 Biogen shares in Q1 2024, an estimated $265K.
  • Dana Investment Advisors first reported a position in Biogen in Q3 2013 and held it in 9 quarters.
  • Dana Investment Advisors's Biogen position peaked at $7.46M in Q4 2014.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Dana Investment Advisors's 13F filing for Q1 2024, filed 15 May 2024.